K. Angela Macfarlane
President & CEO, ForSight VISION4, Inc., Managing Member, ForSight Labs, LLC
Ms. Macfarlane brings broad experience in early stage company creation in her role as a managing member of ForSight Labs, an ophthalmic incubator formed in 2005 in partnership with The Foundry. Over the past nine years, ForSight has started six VISION companies,that have collectively raised over $150M in capital. Ms. Macfarlane currently serves as President and CEO of ForSight VISION4, Inc., a company revolutionizing how drugs are delivered to the back of the eye.
Prior to joining the ForSight Labs team full-time, Ms. Macfarlane served as Chief Technology Counsel to The Foundry and worked closely with several start-ups, including serving as Technology Counsel for Thomas J. Fogarty, M.D., a renowned physician/entrepreneur. Ms. Macfarlane served as in-house counsel at several medical device start-up companies, including TransVascular, Inc. (purchased by Medtronic), AneuRx, Inc. (purchased by Medtronic), and VidaMed Inc. (IPO, purchased by Medtronic). Ms. Macfarlane received her BA in Business Administration from San Francisco State University, and her J.D. from Golden Gate University School of Law.